Connection

Fengcai Zhu to Immunoglobulin M

Back to Details
This is a "connection" page, showing publications Fengcai Zhu has written about Immunoglobulin M.
Fengcai Zhu
Connection Strength
0.121
Immunoglobulin M
  1. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021 02; 21(2):181-192.
    View in: PubMed
    Score: 0.062
  2. Association of viral load with serum biomakers among COVID-19 cases. Virology. 2020 07; 546:122-126.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.